Rationalization of Anti-PD-1 Therapy Using Receptor Occupancy Data to Guide Drug Dosing- a Single Arm Phase II Trial Using Immunomodulation in Relapsed/Refractory Hodgkin Lymphoma

Category Primary study
JournalBLOOD
Year 2024
This article has no abstract
Epistemonikos ID: 5e31a60633c028b176fbba606927027d6262b585
First added on: Jul 12, 2025